Solabia Acquires Mibelle Biochemistry, Seqens' Botanical Actives and IVD Activity, and Xebios Group

Astorg to Acquire Majority Stake in Solabia Group

May 7, 2025

Biotechnology

Astorg has signed a definitive agreement to acquire a majority stake in Solabia Group from TA Associates, with TA reinvesting alongside Astorg. Solabia, a Paris-headquartered biotech ingredients manufacturer with 11 production sites, 8 R&D labs and over 900 employees, will partner with Astorg to accelerate international expansion (particularly in the US and Asia), advance product innovation and pursue targeted M&A.

Azelis Acquires Solchem Nature S.L. to Strengthen Nutraceutical Offering in Spain

April 7, 2025

Food & Beverage

Azelis has acquired 100% of Solchem Nature S.L., a Barcelona-based distributor of raw materials and premium ingredients for the nutraceutical and dietary supplements market. The deal expands Azelis's presence in Spain and adds Solchem's ~14-person team and network of over 250 customers to Azelis's EMEA nutraceutical platform.

ICL Acquires Majority of Lavie Bio's Activities and Assets from Evogene

July 8, 2025

Biotechnology

ICL Group Ltd. has completed the acquisition of the majority of activities and assets of Lavie Bio Ltd., Evogene's ag-biologicals subsidiary, including Lavie Bio's BDD technology platform, microbial bank, pipeline and current commercial products. Evogene also transferred its MicroBoost AI tech-engine for agriculture to ICL as part of the divestiture; Lavie Bio core personnel will move to ICL while certain strategic partnerships remain with Lavie Bio.

Optibrium Acquires BioPharmics LLC

August 31, 2023

Software

Optibrium, a Cambridge-based developer of software and AI solutions for small-molecule drug discovery, has acquired BioPharmics LLC to expand its 3D ligand- and structure-based drug design and visualisation capabilities. The acquisition brings BioPharmics' algorithms and products (including ForceGen, Surflex-Dock, eSim and QuanSA) and its founding scientists into Optibrium's StarDrop platform to strengthen 3D modelling, docking and binding-affinity prediction functionality.

BBI Solutions Acquires IBEX Technologies Inc.

April 8, 2024

Biotechnology

BBI Solutions OEM Limited has acquired IBEX Technologies Inc., a Montreal-based developer and manufacturer of high-precision enzymes and diagnostic solutions, with the transaction closing on April 8, 2024. The acquisition expands BBI's recombinant protein and enzyme capabilities to better serve in-vitro diagnostics (IVD) manufacturers and brings IBEX's staff and contract-manufacturing capabilities into BBI's global operations.

Calibre Scientific Acquires MoBiTec GmbH

January 15, 2024

Biotechnology

Calibre Scientific has acquired MoBiTec GmbH, a German supplier of consumables and services for molecular and cell biology. MoBiTec will be integrated into BIOZOL Diagnostica GmbH (a Calibre subsidiary) to broaden BIOZOL's product range and strengthen the group's capabilities and sales presence in the DACH research, diagnostics, and pharmaceutical markets.